
zzso under development by zzso zzso Inc for the potential treatment of zzso is an zzso zzso combination of the zzso and zzso zzso zzso zzso and the zzso zzso zzso The proposed dual mechanism of action of the compound involves complementary stimulation of central zzso zzso resulting in increased energy expenditure and reduced zzso At the time of publication, zzso was being assessed in phase III clinical zzso zzso data demonstrated zzso weight losses of 3 to zzso and improvements in zzso zzso and cardiovascular risk zzso The primary adverse effect leading to zzso of treatment was zzso Assuming that the results of the zzso phase III clinical program zzso the efficacy and safety of the drug zzso this agent could be approved and launched to become a market leader in the zzso therapeutic zzso 

